Lastly, a study of upstream TERT promoter methylation patterns in 312 PTC, FTC, MTC, and ATC patients found significantly higher upstream DNA methylation in patients with cancer recurrence than in patients whose tumors did not recur. This evidence concerns the gene TERT and cancer.